Vertex Pharmaceuticals
VRTX
$445.21
Share price
1.04%
Change (1 day)
30.48%
Change (1 year)
Categories
Market capitalization of Vertex Pharmaceuticals (VRTX)
Market cap: $114.88 Billion
As of May 2024 Vertex Pharmaceuticals has a market cap of $114.88 Billion. This makes Vertex Pharmaceuticals the world's 130th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Vertex Pharmaceuticals from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $114.88 B | 9.57% |
| 2023 | $104.84 B | 41.44% |
| 2022 | $74.12 B | 32.63% |
| 2021 | $55.88 B | -9.06% |
| 2020 | $61.45 B | 8.38% |
| 2019 | $56.70 B | 34.11% |
| 2018 | $42.28 B | 11.57% |
| 2017 | $37.90 B | 107.41% |
| 2016 | $18.27 B | -41.04% |
| 2015 | $30.99 B | 7.91% |
| 2014 | $28.72 B | 65.35% |
| 2013 | $17.37 B | 90.79% |
| 2012 | $9.10 B | 31.44% |
| 2011 | $6.92 B | -2.85% |
| 2010 | $7.12 B | -16.79% |
| 2009 | $8.56 B | 99.27% |
| 2008 | $4.29 B | 39.3% |
| 2007 | $3.08 B | -34.6% |
| 2006 | $4.71 B | 57.7% |
| 2005 | $2.99 B | 250.55% |
| 2004 | $0.85 B | 5.71% |
| 2003 | $0.80 B | -33.27% |
| 2002 | $1.21 B | -34.42% |
| 2001 | $1.84 B |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Vertex Pharmaceuticals was reported to be:
$114.88 Billion
$114.88 Billion
$114.87 Billion
$114.88 Billion
$113.70 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $372.16 B | 223.94% | 🇺🇸 USA |
 AbbVie ABBV | $293.87 B | 155.79% | 🇺🇸 USA |
 Gilead Sciences GILD | $84.36 B | -26.56% | 🇺🇸 USA |
 Merck MRK | $332.27 B | 189.22% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $89.25 B | -22.31% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | $0.25 B | -99.78% | 🇺🇸 USA |